These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 26512556

  • 21. Clinical Outcome and Prognostic Factors of Intensity-Modulated Radiotherapy for T4 Stage Nasopharyngeal Carcinoma.
    Luo Y, Gao Y, Yang G, Lang J.
    Biomed Res Int; 2016; 2016():4398498. PubMed ID: 27195286
    [Abstract] [Full Text] [Related]

  • 22. A new staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results of a prospective multicentric clinical study.
    Kang M, Long J, Li G, Yan H, Feng G, Liu M, Zhu J, Wang R.
    Oncotarget; 2016 Mar 22; 7(12):15252-61. PubMed ID: 26918446
    [Abstract] [Full Text] [Related]

  • 23. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.
    Liang SB, Deng YM, Zhang N, Lu RL, Zhao H, Chen HY, Li SE, Liu DS, Chen Y.
    BMC Cancer; 2013 May 27; 13():260. PubMed ID: 23710879
    [Abstract] [Full Text] [Related]

  • 24. Does MRI-detected cranial nerve involvement affect the prognosis of locally advanced nasopharyngeal carcinoma treated with intensity modulated radiotherapy?
    Zong J, Lin S, Chen Y, Wang B, Xiao Y, Lin J, Li R, Pan J.
    PLoS One; 2014 May 27; 9(6):e100571. PubMed ID: 24963626
    [Abstract] [Full Text] [Related]

  • 25. Retrospective Analysis of the Survival Benefit of Induction Chemotherapy in Stage IVa-b Nasopharyngeal Carcinoma.
    Lan XW, Zou XB, Xiao Y, Tang J, OuYang PY, Su Z, Xie FY.
    PLoS One; 2016 May 27; 11(8):e0160758. PubMed ID: 27509025
    [Abstract] [Full Text] [Related]

  • 26. Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy.
    Su SF, Han F, Zhao C, Huang Y, Chen CY, Xiao WW, Li JX, Lu TX.
    Chin J Cancer; 2011 Aug 27; 30(8):565-73. PubMed ID: 21801605
    [Abstract] [Full Text] [Related]

  • 27. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
    Fatima K, Andleeb A, Sofi MA, Rasool MT, Fir A, Nasreen S, Dar NA.
    J Cancer Res Ther; 2022 Aug 27; 18(1):133-139. PubMed ID: 35381774
    [Abstract] [Full Text] [Related]

  • 28. Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensity matched analysis.
    Chen YP, Mao YP, Zhang WN, Chen L, Tang LL, Li WF, Liu X, Zhou GQ, Guo R, Sun Y, Kang TB, Zeng MS, Ma J.
    Oncotarget; 2016 Mar 22; 7(12):14973-82. PubMed ID: 26942870
    [Abstract] [Full Text] [Related]

  • 29. Nasopharyngeal carcinoma patients with retropharyngeal lymph node metastases: a minimum axial diameter of 6 mm is a more accurate prognostic predictor than 5 mm.
    Li YZ, Xie CM, Wu YP, Cui CY, Huang ZL, Lu CY, Wu PH.
    AJR Am J Roentgenol; 2015 Jan 22; 204(1):20-3. PubMed ID: 25539232
    [Abstract] [Full Text] [Related]

  • 30. The prognostic value of pretreatment tumor apparent diffusion coefficient values in nasopharyngeal carcinoma.
    Yan DF, Zhang WB, Ke SB, Zhao F, Yan SX, Wang QD, Teng LS.
    BMC Cancer; 2017 Oct 11; 17(1):678. PubMed ID: 29020937
    [Abstract] [Full Text] [Related]

  • 31. The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.
    Chen L, Mao YP, Xie FY, Liu LZ, Sun Y, Tian L, Tang LL, Lin AH, Li L, Ma J.
    Radiother Oncol; 2012 Sep 11; 104(3):331-7. PubMed ID: 22103978
    [Abstract] [Full Text] [Related]

  • 32. The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity-modulated radiotherapy era.
    Tang LL, Liang SB, Huang CL, Zhang F, Xu C, Mao YP, Tian L, Lin AH, Li L, Sun Y, Ma J.
    Cancer Med; 2019 May 11; 8(5):2213-2222. PubMed ID: 30950240
    [Abstract] [Full Text] [Related]

  • 33. Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: A large-scale retrospective study.
    Zhang LL, Zhou GQ, Li YY, Tang LL, Mao YP, Lin AH, Ma J, Qi ZY, Sun Y.
    Cancer Med; 2017 Dec 11; 6(12):2822-2831. PubMed ID: 29034992
    [Abstract] [Full Text] [Related]

  • 34. Prognostic Value of Serum Epstein-Barr Virus Antibodies and Their Correlation with TNM Classification in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma.
    Zhang WR, Du YY, Guo CY, Zhou HX, Lin JY, Meng XH, Mo HY, Luo DH.
    Cancer Res Treat; 2021 Oct 11; 53(4):991-1003. PubMed ID: 33494127
    [Abstract] [Full Text] [Related]

  • 35. MRI of nasopharyngeal carcinoma: parapharyngeal subspace involvement has prognostic value and influences T-staging in the IMRT era.
    Huang W, Quan T, Zhao Q, Li S, Cai Y, Zhou J, Luo C, Ruan G, Cui C, Liang S, Li H, Liu L.
    Eur Radiol; 2022 Jan 11; 32(1):262-271. PubMed ID: 34327576
    [Abstract] [Full Text] [Related]

  • 36. Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    Zhang Y, Li WF, Chen L, Mao YP, Guo R, Zhang F, Peng H, Liu LZ, Li L, Liu Q, Ma J.
    Sci Rep; 2015 Sep 08; 5():13919. PubMed ID: 26345410
    [Abstract] [Full Text] [Related]

  • 37. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
    Zhang L, Tang LQ, Chen QY, Liu H, Guo SS, Liu LT, Guo L, Mo HY, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Shao JY, Sun Y, Ma J, Hong MH, Mai HQ.
    Oncotarget; 2016 Feb 02; 7(5):6221-30. PubMed ID: 26716900
    [Abstract] [Full Text] [Related]

  • 38. [A clinical verification of the Chinese 2008 staging system for nasopharyngeal carcinoma].
    Mao YP, Li WF, Chen L, Sun Y, Liu LZ, Tang LL, Cao SM, Lin AH, Hong MH, Lu TX, Liu MZ, Li L, Ma J.
    Ai Zheng; 2009 Oct 02; 28(10):1022-8. PubMed ID: 19799808
    [Abstract] [Full Text] [Related]

  • 39. MRI-detected skull-base invasion: prognostic value and therapeutic implication in intensity-modulated radiotherapy treatment for nasopharyngeal carcinoma.
    Cheng YK, Liu LZ, Jiang N, Yue D, Tang LL, Zhang F, Lin L, Liu X, Chen L, Ma J.
    Strahlenther Onkol; 2014 Oct 02; 190(10):905-11. PubMed ID: 24763663
    [Abstract] [Full Text] [Related]

  • 40. Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.
    Lv JW, Chen YP, Zhou GQ, Tang LL, Mao YP, Li WF, Guo R, Lin AH, Ma J, Sun Y.
    Oncotarget; 2016 Mar 29; 7(13):16806-17. PubMed ID: 26919237
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.